FDA Investigator Sara M Onyango
Sara M Onyango has inspections in 8 countries as of 18 Oct 2023. Sara M Onyango has collaborated with a combined 1640 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
59
Last Inspection Date:
18 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Germany,
Switzerland,
France,
United Kingdom of Great Britain and Northern Ireland,
Netherlands,
Ireland,
Belgium
Co-Investigator(s):
Abby E Pelletier,
Allison A Rodriguez,
Amber G Wardwell,
Anderson,
Andre S Lamontagne,
Anthony C Warchut,
Ava M Bowman,
Barbara J Rincon,
Bei Y He,
Benjamin J Dastoli,
Benjamin J Smith,
Brenda P King,
Bryan J Love,
Calvin K Cook,
Camerson E Moore,
Charles L Larson,
Charles M Spyr,
Claudette D Brooks,
Clifton L Randell,
Constance Desimone,
Darin S Wiegers,
Darin S Wingers,
David A Paterson,
David C Sullivan,
David M Mcnew,
David M Wilkinson,
David P Vanhouten,
Dawn M Braswell,
Dorothy W Lee,
Elizabeth B Griffin,
Emest F Bizjak,
Erik W Koester,
Evelyn Taha,
Fouad Attioui,
Gary Durbiel Goldner,
George T Allen, Jr,
Ian A Pilcher,
Iris C Macinnes,
James P Finn,
James R Montero,
James W Whitney,
Jason A Rossi,
Jeanette L Mcginnis,
Jeffrey A Sommers,
John A Sciacchitano,
Jonathan B Lewis,
Joseph R Strelnik,
Juanj Wu,
Justine M Corson,
Karl D Hezel,
Kent A Conforti,
Kimberly Lewandowski Walker,
Lauren B Brown,
Lauren M Lawrance,
Laurie B Frazier,
Loretta Nemchik,
Mark A Heard,
Mary Jeanet Mcgarry,
Matthew C Watson,
Maura Rooney,
Maureen L Dreher,
Megan A Haggerty,
Meisha R Sampson,
Meisha Waters,
Michael P Anthony,
Michael P Sweeney,
Michelle M Noe,
Muna Algharibeh,
Mutahar S Shamsi,
Nabil Nakhoul,
Nicholas C Mendiola,
Paul E Stein,
Paul P Geraci,
Philip H Lafleur,
Phillip E Mclaughlin,
Rebecca E Dombrowski,
Robert M Barbosa,
Rodney D Combs,
Sandra P White,
Sara M Richardson,
Scott K Zika,
Scott R Izyk,
Seema S Singh,
Seth A Mailhot,
Stephen C Smith,
Stephen D Eich,
Sunita Pandey,
Suzanne M Healy,
Tamara S Rosbury,
Terry C Kimball,
Thai T Duong,
Vickie L Anderson,
Wendy M Stone,
Yehualashet A Gessesse,
Yvette E Guillermo
Sara M Onyango's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more